HDAC and PD-1 inhibition in humanized triple-negative breast cancer xenografts.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e14604
Abstract: e14604Background: There is great interest in investigating immune checkpoint inhibition in combination with novel agents, however, preclinical studies are limited by the lack of immune-competent human cancer cell line xenograft models. We developed a “hematopoietic”… read more here.
Keywords: inhibition humanized; inhibition; hdac inhibition; cancer ... See more keywords